Vitanova Biomedical
Vitanova Biomedical: A Texas-based biotech firm revolutionizing cancer therapy with light-activated treatments.
Founded
2015Vitanova Biomedical: A Texas-based biotech firm revolutionizing cancer therapy with light-activated treatments.
Vitanova Biomedical, founded in San Antonio, Texas, is an early-stage biotechnology company dedicated to revolutionizing cancer therapy. The company's core mission is to develop transformative cancer treatments utilizing Light-Activated Intracellular Acidosis (LAIA). This innovative approach aims to selectively target and destroy cancer cells while minimizing damage to surrounding healthy tissue. Vitanova Biomedical focuses on providing advanced therapeutic solutions to improve patient outcomes in the oncology market.
Notable affiliated individuals and investors include leading experts in oncology and biotechnology sectors, though specific names are not provided. Key achievements for Vitanova Biomedical include the development and initial testing of their LAIA technology, which has shown promising results in preclinical studies. The company's overall impact lies in its potential to offer a more effective and less invasive cancer treatment option, positioning it as a significant player in the future of oncology therapeutics.
Companies similar to Vitanova Biomedical include Tvax Biomedical, Veana Therapeutics, Stellanova Therapeutics and Sporos Bioventures.
Vitanova Biomedical was founded in 2015.
Vitanova Biomedical's headquarters is located in Kerrville, TX, US.
Vitanova Biomedical's most recent funding round was for $10k (USD) in May 2021.
As of May 20, 2021, Vitanova Biomedical has disclosed funding of $980k (USD). Undisclosed round amounts are excluded.
Vitanova Biomedical has 11 employees as of Feb 5, 2024.
Sporos Bioventures
